Noticias de VIR_US
Noticias del mercado
Últimas noticias sobre VIR_US — 219 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Vir Biotechnology (VIR) stock jumps after Q2 earnings beat and Astellas deal boosts cash to $1B; preview ECLIPSE catalysts and key levels—read now.
Parkman Healthcare Partners LLC acquired a new position in Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 475,279 shares of the
Vir Biotechnology (NASDAQ:VIR) Trading Up 8.1% - What
Vir Biotechnology, Inc. (VIR) se encuentra actualmente a $ 9,84, un aumento de $ 0,35 o 3,69 %. Sería el cierre más alto desde el 10 de julio de 2026, cuando cerró a $ 9,96. ¡Bitget noticias criptográficas!
Vir (VIR) Close and Levels: Adds 1.06% to Close at $9.49 in the Latest Reading; Key Levels: the $9.02 to $9.96 Range Remains in Focus in Latest Trading - Revenue…
Vir (VIR) Close and Levels: Adds 1.06% to Close at $9.49 in the Latest Reading; Key Levels: the $9.02 to $9.96 Range Remains in Focus in Latest Trading - Option…
The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability
Página 8 de 11